What Rapid Medical does

Rapid Medical is an Israeli-founded neurovascular medical device company headquartered in Yokneam, Israel, that develops and commercializes proprietary adjustable interventional devices for the treatment of ischemic and hemorrhagic stroke. The company's core technology platform enables real-time, intra-procedural adjustment of devices in response to patient anatomy — a capability the company describes as unique in the category. Its three product lines are the TIGERTRIEVER family (adjustable stent retrievers for mechanical thrombectomy, including the standard TIGERTRIEVER plus TIGERTRIEVER 13, TIGERTRIEVER XL, and TIGERTRIEVER 25 sizes), the COMANECI temporary aneurysm embolization assist device with an expanded CE mark for vasospasm treatment, and the DRIVEWIRE steerable neurovascular guidewire. All products are protected by 100+ issued patents, supported by 75+ clinical publications, and have cumulatively been used to treat more than 40,000 patients across 30+ countries.

The company's business model is enterprise B2B hardware sales of single-use interventional devices to hospitals and stroke treatment centers, with direct field sales coverage in the US (Southlake, Texas), Germany (Frankfurt), and the UK (London), supplemented by exclusive distribution partnerships — notably Kaneka for Japan and MicroPort as strategic investor and channel partner. Revenue is generated per procedure through device sales; pricing is not publicly disclosed. Rapid Medical has secured FDA clearance for all core products, CE marking for the European portfolio, regulatory approval in China, and Japanese approval via Kaneka. The company has raised approximately $79 million across three disclosed rounds, with the $50 million Series D in 2021 led by MicroPort. Leadership is anchored by co-founder and CEO Ronen Eckhouse alongside an executive team with prior operating experience at Medtronic, BTG-acquired Galil Medical, and several Israeli MedTech ventures.

Name

Rapid Medical

Legal name

Rapid Medical Ltd.

Website

https://rapid-medical.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

101–250 employees

Short description

Rapid Medical is an Israeli neurovascular medical device company that develops and commercializes proprietary, real-time adjustable devices — TIGERTRIEVER thrombectomy systems, COMANECI aneurysm embolization assist, and DRIVEWIRE steerable guidewires — selling them to hospitals and stroke centers in 30+ countries.

Ownership category

akta.pro rank

Product category

Neurovascular Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Thrombectomy, Embolic Protection & Stroke Intervention Devices (HLAHAFAJ)

akta.pro secondary industry

Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems) (HLAHAFAK)

Keywords

• Neurovascular devices
• Thrombectomy devices
• Stroke intervention
• Aneurysm embolization
• Steerable guidewires

Headquarters

HQ city

Yoqne`am `illit

HQ country

Israel

HQ region

Middle East

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Others

Revenue model

1. Neurovascular Medical Devices: Rapid Medical generates revenue through the sale of proprietary neurovascular devices including TIGERTRIEVER thrombectomy devices, COMANECI embolization assist devices, and DRIVEWIRE steerable guidewires to hospitals and healthcare systems globally.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Rapid Medical develops and manufactures proprietary, remotely adjustable neurovascular medical devices for treating ischemic and hemorrhagic stroke. Its portfolio includes adjustable stent retriever thrombectomy devices (TIGERTRIEVER family), an adjustable aneurysm embolization assist device (COMANECI), and steerable neurovascular guidewires (DRIVEWIRE).

Product overview

Rapid Medical develops a portfolio of proprietary, remotely adjustable interventional neurovascular devices for treating ischemic and hemorrhagic stroke. The core products include the TIGERTRIEVER family (TIGERTRIEVER, TIGERTRIEVER 13, TIGERTRIEVER 25, TIGERTRIEVER XL) - adjustable thrombectomy/stent retriever devices for mechanical clot removal in ischemic stroke; COMANECI - an embolization assist device for wide-necked aneurysm treatment and vasospasm; and DRIVEWIRE - the world's first steerable neurovascular guidewire for precise catheter navigation. All products utilize proprietary manufacturing techniques enabling real-time adjustment during procedures to adapt to patient anatomy.

Differentiator

Problem solved

Functional benefit

Brands

• TIGERTRIEVER™: Adjustable thrombectomy devices for ischemic stroke treatment, including TIGERTRIEVER 13 and TIGERTRIEVER 25
• COMANECI™
• DRIVEWIRE™

Products and services

• TIGERTRIEVER The world's first and only FDA-cleared adjustable stent retriever for mechanical thrombectomy in acute ischemic stroke patients, enabling real-time control of expansion during clot retrieval.
• TIGERTRIEVER 13 Smallest adjustable thrombectomy device, designed for distal vessel occlusion treatment in neurovascular procedures.
• TIGERTRIEVER 25 Adjustable thrombectomy device in the TIGERTRIEVER family for ischemic stroke treatment.
• TIGERTRIEVER XL Larger-format adjustable stent retriever variant of TIGERTRIEVER for thrombectomy procedures.
• COMANECI First-of-its-kind adjustable, temporary coil occlusion/embolization assist device used during treatment of intracranial aneurysms, providing bridge support without flow arrest.
• DRIVEWIRE 24 Steerable neurovascular guidewire designed for navigation through tortuous cerebral vasculature during endovascular procedures.

Quantifiable outcome

• 86.3% success rate without symptomatic intracranial hemorrhage in DISTALS trial for medium vessel stroke
• +1 more outcomes

Named customers5 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• KanekamajorChannel Partner/ Reseller/ Distributor · 1 December 2023Rapid Medical announced Japanese approval and exclusive partnership with Kaneka for TIGERTRIEVER - the world's only adjustable thrombectomy device. Kaneka has exclusive rights to distribute TIGERTRIEVER in Japan, representing a significant distribution partnership for the Asian market.

Scale indicators6 records

Recent moves6 records

Expansion highlights8 records

Direct peers

• Penumbra: Penumbra is a direct competitor in mechanical thrombectomy with its Indigo aspiration and RED reperfusion catheter systems for ischemic stroke. It competes head-to-head with TIGERTRIEVER in stroke centers globally and is one of the fastest-growing neurovascular players.
• Phenox: Phenox is a Germany-based neurovascular device company offering stent retrievers, flow diverters, and access products for stroke treatment. It is a closely comparable European peer focused on the same procedural indications and hospital customer base as Rapid Medical.
• Acandis: Acandis is a German neurovascular specialist selling stent retrievers (APERIO), flow diverters, and embolization coils. It is a direct peer in thrombectomy and aneurysm treatment, serving the same European stroke centers as Rapid Medical.
• Balt: Balt is a French neurovascular company offering a broad portfolio of stroke and aneurysm treatment devices, including stent retrievers (CATCH+) and flow diverters. It competes with Rapid Medical across ischemic and hemorrhagic stroke indications globally.

Broad incumbents

• Medtronic: Medtronic offers the Solitaire stent retriever and Riptide aspiration system for stroke thrombectomy within a large diversified neurovascular and broader MedTech portfolio. Rapid Medical's President Americas came from Medtronic's neurovascular division, underscoring direct overlap in customer base and product category.
• Stryker: Stryker's Neurovascular division sells the Trevo stent retriever for ischemic stroke and a broader portfolio of access and embolization devices. As one of the largest incumbent neurovascular players, Stryker represents a direct competitor in Rapid Medical's core thrombectomy and access categories.
• Johnson & Johnson (Cerenovus): Cerenovus, J&J's neurovascular business, offers stent retrievers (EmboTrap), access devices, and embolization products. It competes directly with Rapid Medical across ischemic and hemorrhagic stroke interventions within the J&J MedTech portfolio.
• MicroPort NeuroTech: MicroPort NeuroTech is the neurovascular affiliate of MicroPort, which is Rapid Medical's strategic parent and Series D lead. It sells competing neurovascular devices including Numen coils (which Rapid Medical has already used jointly), making it both a related-party distributor and a partial competitor.

Emerging players

• MIVI Neuroscience: MIVI Neuroscience is a US-based emerging player developing novel stroke intervention devices including the Q aspiration catheter and an investigational stent retriever. It is a smaller-scale peer targeting overlapping ischemic stroke accounts and competing for trial and adoption mindshare with Rapid Medical.
• Imperative Care: Imperative Care is a US-based neurovascular company developing the Zoom stroke reperfusion system including aspiration catheters and a novel stent retriever. It is a venture-backed emerging competitor with overlapping procedural indications and a fast-growing sales effort in the same US accounts Rapid Medical targets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/rapid-medical

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds3 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rapid Medical